Atomoxetine in abstinent cocaine users: Sex differences
Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-10-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340917303888 |
id |
doaj-fc731200ef644ff7ac7c24fa0d55c67d |
---|---|
record_format |
Article |
spelling |
doaj-fc731200ef644ff7ac7c24fa0d55c67d2020-11-24T22:09:53ZengElsevierData in Brief2352-34092017-10-0114C56657210.1016/j.dib.2017.08.011Atomoxetine in abstinent cocaine users: Sex differencesElise E. DeVito0Aryeh I. Herman1Noah S. Konkus2Huiping Zhang3Mehmet Sofuoglu4Department of Psychiatry, Yale School of Medicine, United StatesDepartment of Psychiatry, Yale School of Medicine, United StatesDepartment of Psychiatry, Yale School of Medicine, United StatesDepartment of Psychiatry, Yale School of Medicine, United StatesDepartment of Psychiatry, Yale School of Medicine, United StatesData presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were assessed. The primary atomoxetine dose analyses (which do not consider sex as a factor) are reported in full elsewhere (DeVito et al., 2017) [1].http://www.sciencedirect.com/science/article/pii/S2352340917303888 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elise E. DeVito Aryeh I. Herman Noah S. Konkus Huiping Zhang Mehmet Sofuoglu |
spellingShingle |
Elise E. DeVito Aryeh I. Herman Noah S. Konkus Huiping Zhang Mehmet Sofuoglu Atomoxetine in abstinent cocaine users: Sex differences Data in Brief |
author_facet |
Elise E. DeVito Aryeh I. Herman Noah S. Konkus Huiping Zhang Mehmet Sofuoglu |
author_sort |
Elise E. DeVito |
title |
Atomoxetine in abstinent cocaine users: Sex differences |
title_short |
Atomoxetine in abstinent cocaine users: Sex differences |
title_full |
Atomoxetine in abstinent cocaine users: Sex differences |
title_fullStr |
Atomoxetine in abstinent cocaine users: Sex differences |
title_full_unstemmed |
Atomoxetine in abstinent cocaine users: Sex differences |
title_sort |
atomoxetine in abstinent cocaine users: sex differences |
publisher |
Elsevier |
series |
Data in Brief |
issn |
2352-3409 |
publishDate |
2017-10-01 |
description |
Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were assessed. The primary atomoxetine dose analyses (which do not consider sex as a factor) are reported in full elsewhere (DeVito et al., 2017) [1]. |
url |
http://www.sciencedirect.com/science/article/pii/S2352340917303888 |
work_keys_str_mv |
AT eliseedevito atomoxetineinabstinentcocaineuserssexdifferences AT aryehiherman atomoxetineinabstinentcocaineuserssexdifferences AT noahskonkus atomoxetineinabstinentcocaineuserssexdifferences AT huipingzhang atomoxetineinabstinentcocaineuserssexdifferences AT mehmetsofuoglu atomoxetineinabstinentcocaineuserssexdifferences |
_version_ |
1725810232702009344 |